A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis




TekijätPolari L, Anttila S, Helenius T, Wiklund A, Linnanen T, Toivola DM, Määttä J

KustantajaMDPI

Julkaisuvuosi2019

JournalInternational Journal of Molecular Sciences

Tietokannassa oleva lehden nimiINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Lehden akronyymiINT J MOL SCI

Artikkelin numeroARTN 3007

Vuosikerta20

Numero12

Sivujen määrä14

ISSN1422-0067

eISSN1422-0067

DOIhttps://doi.org/10.3390/ijms20123007

Verkko-osoite10.3390/ijms20123007

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/41737986


Tiivistelmä
Estrogen-receptor-mediated signaling has been suggested to decrease the inflammatory response in monocyte macrophages. Previously, we showed that a novel selective estrogen receptor modulator (SERM2) promotes anti-inflammatory phenotype of monocytes in vitro. In this study, we demonstrate the potential of SERM2 in amelioration of colitis. We utilized a dextran sodium sulfate (DSS)-induced colitis model in FVB/n mice to demonstrate the effects of orally administered SERM2 on the clinical status of the mice and the histopathological changes in the colon, as well as proportion of Mrc-1 positive macrophages. SERM2 nuclear receptor affinities were measured by radioligand binding assays. Orally administered, this compound significantly alleviated DSS-induced colitis in male mice and induced local estrogen receptor activation in the inflamed colon, as well as promoting anti-inflammatory cytokine expression and infiltration of anti-inflammatory monocytes. We show that this novel drug candidate has an affinity to estrogen receptors alpha and beta and progesterone receptors, but not to glucocorticoid receptor, thus expressing unique binding properties compared to other sex steroid receptor ligands. These results indicate that novel drug candidates to alleviate inflammatory conditions of the colon could be found among sex steroid receptor activating compounds.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:33